SCHEMBL32665265

SCHEMBL32665265

O=C(NCCN1C(=O)C=CC1=O)c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.50
OPRD1 P41143 3/20 0.50
OPRK1 P41145 3/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 2/20 0.48
GFER P55789 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
RAB9A P51151 2/20 0.48
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HDAC2 Q92769 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665387 0.91 OPRM1 (0.52) OPRM1OPRD1OPRK1GAAGFER
SCHEMBL31138818 0.86 CD274 (0.52) KMT2AMEN1RAB9ANPC1
SCHEMBL9610832 0.86 CD274 (0.52) KMT2AMEN1RAB9ANPC1
SCHEMBL16731692 0.86 NPSR1 (0.58) KMT2AMEN1RAB9ANPC1CYP2C19
SCHEMBL3503130 0.85 GAA (0.61) KMT2AMEN1GAACYP1A2CYP2D6
SCHEMBL32665539 0.82 KDM4E (0.51) KMT2AMEN1GAACYP1A2CYP2D6
SCHEMBL15393707 0.81 KMT2A (0.61) KMT2AMEN1
SCHEMBL1161862 0.78 GFER (0.64) GAAGFERCYP1A2CYP2D6RAB9A
SCHEMBL32665129 0.78 GLA (0.43) KMT2AMEN1GAARAB9ANPC1
SCHEMBL16868846 0.77 L3MBTL1 (0.57) KMT2AMEN1GAARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A OPRM1 849/4885OPRD1 1078/4885OPRK1 2373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.